Neurology Book

http://www.fpnotebook.com/

Rivastigmine

Aka: Rivastigmine, Exelon
  1. See Also
    1. Tacrine (Cognex)
    2. Donepezil (Aricept)
  2. Indications
    1. Alzheimer's Disease related Dementia
  3. Mechanism
    1. Carbamate-based noncompetitive cholinesterase inhibitor
    2. Inhibits butyrylcholinesterase and acetylcholinesterase
    3. Increases cholinergic transmission
  4. Pharmacokinetics
    1. Peak: 1 hour
    2. Duration: 10 hours
  5. Drug Interactions
    1. No significant drug interactions
  6. Efficacy
    1. Modestly improves scores on neuropsychological tests
    2. Benefits decrease after 40 weeks of treatment
  7. Adverse Effects
    1. Nausea or Vomiting
    2. Diarrhea
    3. Abdominal Pain
    4. Anorexia
    5. Weight loss
    6. No hepatotoxicity risk (contrast with Tacrine)
  8. Dosing
    1. Initial: 1.5 mg PO bid with food
    2. Increase dose by 1.5 mg every 2 weeks up to 6 mg bid
  9. Cost
    1. (2003) Red Book: $130/month
  10. References
    1. (2000) Med Lett Drugs Ther 42(1089):93-4
    2. Corey-Bloom (1998) Int J Geriatr Psychopharm 1:55
    3. Rosler (1999) BMJ 318:633

Exelon (C0730987)

Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH C072506
English Exelon, rivastigmine (Exelon), exelon
Sources
Derived from the NIH UMLS (Unified Medical Language System)


rivastigmine (C0649350)

Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH C072506
SnomedCT 323368009, 395868008
English (S)-N-ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate, Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1), rivastigmine, rivastigmine (medication), RIVASTIGMINE, rivastigmine [Chemical/Ingredient], Rivastigmine, Rivastigmine (product), Rivastigmine (substance)
Spanish rivastigmina (producto), rivastigmina (sustancia), rivastigmina
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Navigation Tree